Netherlands· NL-ef2e1ba5555f
Ducressa 1 mg/ml / 5 mg/ml, oogdruppels, oplossing
A dexamethason mit antiinfektiva product containing dexamethasondinatriumfosfaat + levofloxacine 0,5-water, registered in Netherlands by Santen Oy. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Dexamethason mit antiinfektiva is registered in 11 of 19 countries.
Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Dexamethason mit antiinfektiva · ATC S01CA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DEXAMETHASONDINATRIUMFOSFAAT + LEVOFLOXACINE 0,5-WATER
- Manufacturer
- Santen Oy
- Country
- Netherlands (NL)
- ATC code
- S01CA01
- ATC class
- Dexamethason mit Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id124826
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethason mit antiinfektiva in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandDucressaDelfarma Sp. z o.o.
- SpainDUCRESSA 1 MG/ML + 5 MG/ML COLIRIO EN SOLUCIONSanten Oy
- United KingdomDucressa 1mg/ml / 5mg/ml eye dropsSanten UK Ltd
- IrelandDucressa 1 mg/ml + 5 mg/ml, eye drops, solutionSanten OY
- IcelandDucressaSanten Oy*
- NorwayDucressaSanten Oy (1)
- GermanyLevendexNtc Srl
- SwedenDucressa 1 mg/ml + 5 mg/ml Ögondroppar, lösningSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Ducressa
- Bulgaria · Ducressa
- Germany · Levendex
- Estonia · Ducressa
- Greece · Ducressa
- Croatia · Ducressa
- Ireland · Ducressa
- Italy · Ducressa, Leviosa
- Lithuania · Ducressa
- Norway · Ducressa
- Romania · Ducressa Md
- Sweden · Ducressa
- Slovenia · Ducressa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee1c3266-d649-4c99-b31e-bbfbe46aa807 GET /v1/drugs/ee1c3266-d649-4c99-b31e-bbfbe46aa807?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h124826_smpc.pdf",
"strength": null,
"atc_label": "Dexamethasone And Antiinfectives",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg124826",
"excipients": [
"BENZALKONIUMCHLORIDE",
"DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
"NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"TRINATRIUMCITRAAT 2-WATER (E 331)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"DEXAMETHASONDINATRIUMFOSFAAT",
"LEVOFLOXACINE 0,5-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h124826.pdf",
"authorised_at": "2020/06/29",
"procedure_number": "DE/H/6216/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "124826",
"additional_monitoring": "N"
}See everything about dexamethason mit antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.